OGN (OGN)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9, Altman Z 1.1.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency of OGN presents a mixed fundamental profile characterized by high leverage driving returns rather than operational scale. While the DuPont decomposition reveals that an equity multiplier of 17.11x is the primary engine behind the 24.9% ROE, this aggressive financial structure yields only a modest +1.0% spread between its 7.0% ROIC and 6.0% WACC, indicating limited value creation beyond cost of capital. Credit risk metrics are notably concerning; an Altman Z-Score of 1.1 signals potential distress territory, contrasting sharply with the negative Beneish M-Score of -2.66 which suggests low earnings manipulation risk but fails to offset solvency concerns. Operational momentum is further dampened by a contraction in revenue growth of -2.9% YoY and a relatively weak Piotroski F-Score of 5/9, suggesting the company lacks the financial strength or profitability improvements typically associated with high-quality issuers despite maintaining healthy gross margins near 53%.
Valuation metrics appear compressed relative to historical norms and sector peers, trading at a P/E multiple of 12.3x that may reflect market skepticism regarding its debt-heavy balance sheet rather than pure value opportunity. The DCF analysis implies an intrinsic fair value of $13, suggesting the current price could be undervalued if future cash flows stabilize; however, this model relies on significant assumptions to overcome the headwinds presented by negative revenue growth and a narrow ROIC-WACC spread. Essentially, the market is pricing in substantial downside risk from potential liquidity constraints while simultaneously acknowledging that the low multiple might offer a margin of safety contingent on successful deleveraging or operational turnaround.
Risk assessment highlights a dichotomy between credit fragility and earnings integrity. The distressed Altman Z-Score introduces significant tail risk regarding solvency, whereas the negative Beneish M-Score provides some confidence in reported net margins despite the shrinking top line. With insider flow remaining neutral over the last 90 days, there is no clear signal of management conviction or distress selling to guide sentiment. The investment thesis hinges entirely on whether the market can sustain this high-leverage model without triggering a credit event that would invalidate current valuation assumptions.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
Sensitivity Matrix
| TG ↓ / WACC → | 6% | 6% | 8% |
|---|---|---|---|
| 2% | $3 | $3 | $0 |
| 3% | $13 | $13 | $0 |
| 4% | $32 | $32 | $1 |
Center = base case. Green = >10% upside, Red = >10% downside vs $13.38.
Pre-computed DCF: WACC=6.0%, terminal growth 3%. Fair value $13 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-05-11 | $0.0200 | 0.0% |
| 2026-02-23 | $0.0200 | 0.0% |
| 2025-11-20 | $0.0200 | 0.0% |
| 2025-08-15 | $0.0200 | 0.0% |
| 2025-05-12 | $0.0200 | -92.9% |
| 2025-02-24 | $0.2800 | 0.0% |
| 2024-11-12 | $0.2800 | 0.0% |
| 2024-08-16 | $0.2800 | 0.0% |
| 2024-05-10 | $0.2800 | 0.0% |
| 2024-02-23 | $0.2800 | 0.0% |
| 2023-11-10 | $0.2800 | 0.0% |
| 2023-08-17 | $0.2800 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XPH or SLYV, the fund manager is mechanically forced to buy or sell OGN shares regardless of OGN's individual fundamentals. We estimate $130M of passive capital is structurally linked to OGN through 8 tracked ETFs. Passive flows have a limited but growing influence on OGN's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in OGN to visualize passive redemption contagion across ETFs and collateral stocks.
If OGN (OGN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies CORCEPT THERAPEUTICS INC (CORT) as the most exposed collateral stock, sharing 2 ETFs with OGN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 9 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
OGN Ownership Dynamics
Passive funds hold 1 in every 25 OGN shares, reducing daily market volatility.
OGN (OGN) exerts measurable gravity on the passive index market, currently representing 3.8% of the XPH (XPH) and 0.4% of the SLYV (SLYV). Across 9 tracked ETFs, approximately 11M shares (4.1% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.
ETFs with Highest OGN Exposure
Float lock-up computed from 9 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
OGN Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for OGN over the past year sits near $13.29 (20% of 252-day volume). The current price of $13.38 trades 0.7% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (20% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
OGN Capital Efficiency
How efficiently does OGN convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
OGN converts 30% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 70% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 1.0% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 3 | $13.34 | $40.02 |
| 2026-05-13 | 638 | $13.31 | $8,491.78 |
| 2026-05-12 | 64 | $13.33 | $853.12 |
| 2026-05-11 | 11,054 | $13.35 | $147,570.9 |
| 2026-05-08 | 295 | $13.32 | $3,929.4 |
| 2026-05-07 | 1,249 | $13.41 | $16,749.09 |
| 2026-05-06 | 6,476 | $13.35 | $86,454.6 |
| 2026-05-05 | 891 | $13.26 | $11,814.66 |
| 2026-05-04 | 26 | $13.29 | $345.54 |
| 2026-05-01 | 254 | $13.25 | $3,365.5 |
| 2026-04-29 | 39,608 | $13.32 | $527,578.56 |
| 2026-04-28 | 219,881 | $13.16 | $2.9M |
| 2026-04-27 | 20,071 | $11.26 | $225,999.46 |
| 2026-04-23 | 12 | $9.14 | $109.68 |
| 2026-04-17 | 5,407 | $9.33 | $50,447.31 |
| 2026-04-15 | 565 | $8.70 | $4,915.5 |
| 2026-04-13 | 9,291 | $8.83 | $82,039.53 |
| 2026-04-07 | 10 | $6.05 | $60.5 |
| 2026-04-06 | 10 | $6.36 | $63.6 |
| 2026-03-31 | 443 | $5.70 | $2,525.1 |
| 2026-03-30 | 1,065 | $5.84 | $6,219.6 |
| 2026-03-25 | 12 | $6.11 | $73.32 |
| 2026-03-23 | 1,006 | $6.03 | $6,066.18 |
| 2026-03-19 | 318 | $6.23 | $1,981.14 |
| 2026-03-16 | 2,021 | $6.35 | $12,833.35 |
| 2026-03-12 | 6,836 | $6.40 | $43,750.4 |
| 2026-03-11 | 10,799 | $6.48 | $69,977.52 |
| 2026-03-04 | 405 | $6.90 | $2,794.5 |
| 2026-02-25 | 58 | $8.14 | $472.12 |
| 2026-02-23 | 3,110 | $8.10 | $25,191 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare OGN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.